Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11 GBX | -4.35% | -4.35% | +4.76% |
Apr. 17 | Bivictrix granted FDA orphan drug status for rare cancer treatment | AN |
Apr. 17 | BiVictriX Wins US FDA's Orphan Drug Status for Blood Cancer Treatment | MT |
- Stock Market
- Equities
- BVX Stock
- News BiVictriX Therapeutics Plc
- MarketScreener Strategies